Sunday, March 28, 2010

Markets in Brief

Markets in Brief

Ha'aretz - 55 minutes ago

Teva Pharmaceutical Industries says the US Food and Drug Administration gave it tentative approval last week for its generic version of the anticoagulant Argatroban. The version in question is 100 ...


http://digg.com/u1RvzK

No comments:

Post a Comment